Argatroban Side Effects
Not all side effects for argatroban may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
For the Consumer
Applies to argatroban: intravenous solution
In addition to its needed effects, some unwanted effects may be caused by argatroban. In the event that any of these side effects do occur, they may require medical attention.
If any of the following side effects occur while taking argatroban, check with your doctor or nurse immediately:More common
- Bleeding from the bladder
- blood in the urine
- blurred vision
- chest pain
- dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly
- no blood pressure or pulse
- stopping of heart
- unusual tiredness or weakness
- Arm, back, or jaw pain
- bloody or black, tarry stools
- chest tightness or heaviness
- cough or hoarseness
- coughing or spitting up blood
- fast, slow, or irregular heartbeat
- fast, pounding, or irregular heartbeat or pulse
- lower back or side pain
- pain or discomfort in the arms, jaw, back, or neck
- painful or difficult urination
- severe stomach pain
- shortness of breath
- vomiting of blood or material that looks like coffee grounds
- Abdominal pain or swelling
- back pain or backaches
- blue lips and fingernails
- changes in skin color
- cold hands and feet
- coughing that sometimes produces a pink frothy sputum
- difficult, fast, noisy breathing, sometimes with wheezing
- increased sweating
- loss of appetite
- pain, redness, or swelling in the arm or leg
- pains in the chest, groin, or legs, especially calves of the legs
- pale skin
- passing of gas
- severe headaches of sudden onset
- stomach pain, fullness, or discomfort
- sudden loss of coordination
- sudden onset of shortness of breath for no apparent reason
- sudden onset of slurred speech
- sudden vision changes
- swelling in the legs and ankles
For Healthcare Professionals
Applies to argatroban: intravenous solution
Hematologic side effects including overt bleeding or hemorrhage are the most common complications of argatroban therapy. Major hemorrhagic events reported by the manufacturer include gastrointestinal bleeding (2.3%), intracranial bleeding (about 1% in patients receiving both argatroban and thrombolytic therapy), genitourinary bleeding and hematuria (0.9%), decreases in hemoglobin/hematocrit (0.7%), multisystem hemorrhage/DIC (0.5% ), and limb/below the knee amputation (0.5%). Minor hemorrhagic events reported by the manufacturer include gastrointestinal bleeding (14.4%), genitourinary bleeding and hematuria (11.6%), minor decreases in hemoglobin/hematocrit (10.4%), groin bleeding (5.4%), hemoptysis (2.9%), brachial bleeding (2.4%).
In a study of patients given argatroban for the treatment of heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome, one patient experienced intracranial hemorrhage 4 days after the discontinuation of argatroban therapy and following urokinase and oral anticoagulation therapy.
Cardiovascular side effects include hypotension (7.2%), cardiac arrest (5.8%), ventricular tachycardia (4.8%), atrial fibrillation (3.0%) and cerebrovascular disorder (2.3%).
Gastrointestinal side effects include diarrhea (6.2%), nausea (4.8%), vomiting (4.2%), and abdominal pain (2.6%).
Respiratory effects include dyspnea (8.1%), pneumonia (3.3%) and coughing (2.8%).
General side effects include fever (6.9%), sepsis (6.0%) and pain (4.6%).
Genitourinary side effects include urinary tract infection (4.6%).
Immunological side effects include infection (3.7%).
More about argatroban
- Other brands: Acova
Related treatment guides
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.